Lexofenac

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3578QN1B5H. European Medicines Agency schedules Lexofenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08500MIG. Lexofenac generally arises in the molecular formula C14H14O3. The term LEXOFENAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, no 10 1978, list 18.) LEXOFENAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lexofenac under HS 29183000 and SITC 51395. As of Q4 2014, LEXOFENAC remains the US FDA Preferred Term for this commodity. Lexofenac bears US NLM identifiers UMLS ID C1881374 and NCI Concept Code C66011. SMILES: O=C1CCCC(=C1)C1CCC(CC1)CC(=O)O.